How does addiction impact brain structure and function?

Addiction produces durable changes in brain chemistry, circuitry, and structure that help explain compulsive drug seeking and difficulty sustaining recovery. Nora D. Volkow at the National Institute on Drug Abuse, George F. Koob at the National Institute on Alcohol Abuse and Alcoholism, and A. Thomas McLellan at the University of Pennsylvania summarize evidence that addiction is a chronic brain disorder whose hallmark is pathological learning about drugs that overrides other goals.

Changes in neurochemistry and reward circuits

Repeated drug exposure alters the brain’s reward pathways, particularly mesolimbic dopamine projections from the ventral tegmental area to the nucleus accumbens. Positron emission tomography studies led by Nora D. Volkow at the National Institute on Drug Abuse show reductions in dopamine D2 receptor availability and blunted dopamine release in people with substance use disorders. Those neurochemical shifts make ordinary rewards less satisfying and increase the motivational value of drug-related cues, producing intense craving and cue-triggered relapse. Eric J. Nestler at the Icahn School of Medicine at Mount Sinai has characterized how these neurochemical changes are accompanied by synaptic plasticity and altered gene expression in reward-related neurons, including epigenetic modifications that can stabilize drug-induced behavioral changes.

Structural and functional alterations

Functional MRI and structural MRI studies demonstrate that addiction affects prefrontal cortical regions responsible for decision-making, impulse control, and behavioral flexibility. Reduced activity and gray matter loss in the orbitofrontal cortex and dorsolateral prefrontal cortex are associated with impaired inhibitory control and a tendency to favor immediate rewards despite long-term harm. Neuroimaging work by Nora D. Volkow at the National Institute on Drug Abuse links these frontal deficits to increased activity in limbic regions that encode stress and reward salience, such as the amygdala. George F. Koob at the National Institute on Alcohol Abuse and Alcoholism describes how chronic drug use dysregulates stress systems, engaging the extended amygdala and corticotropin releasing factor pathways that drive negative emotional states during withdrawal.

Causes, consequences, and context

The neural changes arise from repeated pharmacological effects on neurotransmitter systems and from learning processes that reinforce drug-seeking behavior. Environmental factors such as early life stress, social disadvantage, and cultural norms around substance use interact with biology to shape risk. Territorially concentrated poverty and limited access to health care increase exposure and reduce opportunities for evidence-based treatment, amplifying the public health impact in some communities. Consequences include cognitive deficits, heightened relapse risk, increased susceptibility to comorbid psychiatric and medical conditions, and intergenerational effects when caregiving and social stability are disrupted.

Potential for recovery

Although many neural adaptations are long-lasting, research indicates the brain retains plasticity and some structural and functional recovery is possible with sustained abstinence and treatment. Behavioral therapies and medication-assisted treatment can normalize aspects of reward function and strengthen executive control circuits, as noted by Nora D. Volkow at the National Institute on Drug Abuse and by clinical reviews from researchers at major academic institutions. Understanding addiction as a brain disorder shaped by biology and environment supports interventions that combine medical, psychological, and social approaches tailored to individual and community needs.